Magnetic nanoparticles for MR imaging: agents, techniques and cardiovascular applications.
about
Nanoparticle-based systems for T(1)-weighted magnetic resonance imaging contrast agentsStealth filaments: Polymer chain length and conformation affect the in vivo fate of PEGylated potato virus X.Virus-based nanomaterials as positron emission tomography and magnetic resonance contrast agents: from technology development to translational medicineFabrication and Properties of Carbon-Encapsulated Cobalt Nanoparticles over NaCl by CVDImaging systemic inflammatory networks in ischemic heart diseaseSelective killing of cancer cells by nanoparticle-assisted ultrasound.Multimodality imaging of myocardial injury and remodeling.Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases.Molecular imaging in atherosclerosis, thrombosis, and vascular inflammation.Steady-state equilibrium phase inversion recovery ON-resonant water suppression (IRON) MR angiography in conjunction with superparamagnetic nanoparticles. A robust technique for imaging within a wide range of contrast agent dosages.Stable aqueous dispersion of superparamagnetic iron oxide nanoparticles protected by charged chitosan derivativesMolecular Imaging of Myocardial Injury: A Magnetofluorescent ApproachChallenges for Molecular Neuroimaging with MRI.Targeted probes for cardiovascular MRIDextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics, and therapy.Subtle cytotoxicity and genotoxicity differences in superparamagnetic iron oxide nanoparticles coated with various functional groups.Magnetic nanoparticles in magnetic resonance imaging and diagnostics.Effect of nano-scale curvature on the intrinsic blood coagulation system.Will nanotechnology influence targeted cancer therapy?Imaging of apoptosis in the heart with nanoparticle technology.Tumor-targeted RNA-interference: functional non-viral nanovectors.Report of the National Heart, Lung, and Blood Institute working group on the translation of cardiovascular molecular imaging.Improving the magnetic resonance imaging contrast and detection methods with engineered magnetic nanoparticlesProtective effect of the apoptosis-sensing nanoparticle AnxCLIO-Cy5.5.From molecules to myofibers: multiscale imaging of the myocardiumMagnetic nanoparticles sensitize MCF-7 breast cancer cells to doxorubicin-induced apoptosis.Magnetically Targeted Stem Cell Delivery for Regenerative Medicine.Multimodal iron oxide nanoparticles for hybrid biomedical imaging.Targeted imaging of breast tumor progression and therapeutic response in a human uMUC-1 expressing transgenic mouse model.Short and long term, in vitro and in vivo correlations of cellular and tissue responses to mesoporous silicon nanovectors.Magnetic and Plasmonic Contrast Agents in Optical Coherence Tomography.Copper-64 Radiopharmaceuticals for Oncologic ImagingNanoscale assembly of amine functionalized colloidal iron oxide.A review of imaging agent development.Toxicity of therapeutic nanoparticles.Magnetic resonance imaging of multifunctional pluronic stabilized iron-oxide nanoparticles in tumor-bearing mice.Copper-64 radiopharmaceuticals for PET imaging of cancer: advances in preclinical and clinical research.Molecular MRI of Atherosclerotic Plaque With Targeted Contrast Agents.Superparamagnetic Nanoparticles for Atherosclerosis ImagingCardiomyocyte death: insights from molecular and microstructural magnetic resonance imaging.
P2860
Q26824262-70D815A3-F2E4-4B7A-A905-C251E3B70A12Q27334548-8EB84CF9-93BD-4C9B-BF87-8F858751DAF5Q28550482-3CF7E501-4EF6-4497-AA64-CF70B964F826Q28828780-ED8AB91B-35A0-4501-A24A-4FF40B7AC03FQ30316648-91ECA1EA-4543-4DBA-8F43-BC8E93DCFF98Q30381377-BC941218-DA06-42EF-9B95-920B3332FC2BQ30432655-FE6E88FE-2D76-4C4B-805B-6A6A1207179EQ30475719-FBD3E144-F962-4363-92E9-3BE66C1DB41AQ30484224-D37656F4-0502-4472-AA38-FC40ABF73813Q30590207-76116DE7-A267-4432-82C5-ABAD82958C8EQ30590849-89B28146-8348-497F-ABFF-BC1B813C6AC6Q33596970-462A6593-0E64-455E-B59A-AF65ED61399DQ33680025-20767D6E-90CB-4BC0-A8B1-8247A700CA90Q33901726-0ADD8131-D35B-483E-A1CD-3998EABE5F9CQ33929151-66169A52-3F67-4B27-85FE-FB177041411AQ34124910-B92216AB-B1EF-43A4-A937-F7C7B9BF0219Q34185314-4890BED8-097A-4785-A6D4-19C60DD1EC15Q34473963-C26B98D7-E26D-4C77-961D-FB830B86C6D5Q34706794-FAC9E8DA-E4A7-4667-97F9-21004833D300Q34913604-BAB224CD-0F87-4274-BC53-B5A325E8E926Q34974957-BFF5C1D2-0D58-4ADF-BFF2-AA31B4C4E0B9Q35058188-26A10245-BA8E-4FB2-8DE8-45A93E3F8930Q35687164-00F6C3A5-19EF-47AB-867B-B5D799CEF4A9Q35869102-A3CC4F5B-FC86-4D7B-8C0B-12A2E39F62C6Q36019181-69D72D12-BD58-4E34-BFA9-86D1F0771BE9Q36125563-C67EEE0B-7FAD-4BDA-A34F-01627B7ABFBAQ36138808-38310C39-A062-4635-A6F4-F46EEAB0FFC2Q36545276-C0019B5E-A26E-4982-A609-01533ED7278DQ36612156-7EF71940-AFF9-49C3-8C1D-DC16FE5724FDQ36999091-03AE0C78-5993-4C3F-83BA-91312A62A0C2Q37087452-8D3324A4-D4B9-4602-9807-B5A183904E0CQ37126530-5707A041-71C3-42B0-AD62-5CA372A497FBQ37168850-F0E5FDD8-49C3-449B-899E-E8E4DDE9713AQ37214528-06E18D86-3F26-404E-8C71-A566656E0AF6Q37385444-EFAAFBF5-1D34-4647-857A-ACEB9B196ADDQ37392147-74C6470D-7609-46BB-AF3B-174031AB313DQ37478003-7D26ECE3-01D8-4718-97CE-AE68EC19E96BQ37478426-4F626A46-D535-4C2F-A3E1-F9D4128531E6Q37638513-AF4DBE8A-3354-492D-94CF-11445DF1406AQ37836529-97AB1BF4-A44C-4E70-B67D-E89C65D18649
P2860
Magnetic nanoparticles for MR imaging: agents, techniques and cardiovascular applications.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Magnetic nanoparticles for MR ...... d cardiovascular applications.
@en
Magnetic nanoparticles for MR ...... d cardiovascular applications.
@nl
type
label
Magnetic nanoparticles for MR ...... d cardiovascular applications.
@en
Magnetic nanoparticles for MR ...... d cardiovascular applications.
@nl
prefLabel
Magnetic nanoparticles for MR ...... d cardiovascular applications.
@en
Magnetic nanoparticles for MR ...... d cardiovascular applications.
@nl
P2860
P921
P1476
Magnetic nanoparticles for MR ...... d cardiovascular applications.
@en
P2093
David E Sosnovik
Matthias Nahrendorf
P2860
P2888
P304
P356
10.1007/S00395-008-0710-7
P577
2008-03-01T00:00:00Z